Laws, Alison
Katlin, Fisher
Hans, Marybeth
Graichen, Mary
Kantor, Olga
Minami, Christina
Bychkovsky, Brittany L.
Pace, Lydia E.
Scheib, Rochelle
Garber, Judy E.
King, Tari A.
Funding for this research was provided by:
Komens Scholar Award
Rebecca Winn Matchett, Christopher Matchett, and the Winn Family Foundation
Article History
Received: 3 June 2022
Accepted: 2 August 2022
First Online: 28 September 2022
Disclosure
: Tari A. King reports speaker’s honoraria and advisory board participation for Exact Sciences (formerly Genomic Health) and serves on the Global Advisory Board, Besins Healthcare. Judy E. Garber reports institutional research funding from Myriad Genetics, Ambry Genetics and Invitae Genetics; consulting for Helix Genetics (compensation) and Earli (no compensation); leading two clinical trials for AstraZeneca; serving on the scientific advisory board of Konica Minolta (no compensation); conducting a sponsored lecture for Clinical Care Options, LLC; Editorial Services publications, President, Fellows of the AACR Academy, and member, Foundation Board of the American Association for Cancer Research; co-scientific director, Breast Cancer Research Foundation; board of directors, Facing Our Risk of Cancer Empowered; spousal consulting fees from Novartis Oncology, GTx Pharmaceuticals, Aleta BioTherapeutics and H3 Biomedicine, Inc.; a spousal advisory board membership at Oric Pharmaceuticals; and spousal scientific advisory board memberships at Kronos Bio, Susan G. Komen for the Cure, James P. Wilmot Foundation, Inc., Diane Helis Henry Medical Research Foundation, Adrienne Helis Melvin Medical Research Foundation, and Global Biological Standards Institute.